UiPath (PATH) Shares Plummeted 7% After-Hours Despite Q2 Beat

UiPath Inc. (PATH) PT Raised to $74 at Morgan Stanley

Morgan Stanley analyst Keith Weiss raised the price target on UiPath Inc. (NYSE: PATH) to $74.00 (from $72.00) while maintaining a Equalweight rating.

UiPath Inc. (PATH) PT Lowered to $80 at Cowen

Cowen analyst Bryan Bergin lowered the price target on UiPath Inc. (NYSE: PATH) to $80.00 (from $84.00) while maintaining an Outperform rating.

The analyst commented, "2Q reflected continued demand strength w/ ARR +60% y/y on robust 144% net retention. PATH upped 2H ARR outlook above... More

UiPath (PATH) Beats Q2 Estimates but Shares Fall Amid Confusion on Right Growth Metric, Analysts Remain Cautious

Shares of UiPath (NYSE: PATH) are down about 7% in pre-open Thursday despite the company delivering better-than-expected Q2 results.

PATH delivered EPS of $0.01 to top the analyst consensus of negative $0.05. Revenue surged 40% to $195.5 million versus the consensus estimate of $184.41 million, while ARR revenue soared 60% to $726.5 million.

We continued our very strong momentum in the second quarter of fiscal year 2022 with ARR growing 60 percent year-over-year to $726.5 million. Our results were driven by both new customer additions, ending the quarter with more than 9,100 customers, as well as robust expansion with existing customers, reflected in our best-in-class... More

UiPath Inc. (PATH) Tops Q2 EPS by 6c

UiPath Inc. (NYSE: PATH) reported Q2 EPS of $0.01, $0.06 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $195.5 million versus the consensus estimate of $184.41 million.

GUIDANCE:

UiPath Inc. sees Q3 2022 revenue of $207-209 million.

For earnings history and earnings-related data on UiPath Inc. (PATH) click here.